Search research articles
Contact Us
Filters
Showing results (1-10 of 103) with videos related to
Page
of 11
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2015
Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no
Jordi Río
Medicina Clinica
|
March 4, 2015
[Current description of multiple sclerosis]
Jordi Río, Xavier Montalbán
Expert Opinion on Pharmacotherapy
|
December 2, 2005
Interferon-beta 1b in the treatment of multiple sclerosis
Jordi Río, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 20, 2018
Clinical commentary on "Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica"
Breogán Rodríguez-Acevedo, Jordi Río
Current Opinion in Neurology
|
April 19, 2011
Multiple sclerosis: current treatment algorithms
Jordi Río, Manuel Comabella, Xavier Montalban
Journal of the Neurological Sciences
|
January 27, 2016
Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis
Jordi Río, Juan Luís Ruiz-Peña
Nature Reviews. Neurology
|
October 2, 2009
Predicting responders to therapies for multiple sclerosis
Jordi Río, Manuel Comabella, Xavier Montalban
Neuroimaging Clinics of North America
|
April 11, 2017
MR Imaging in Monitoring and Predicting Treatment Response in Multiple Sclerosis
Jordi Río, Cristina Auger, Àlex Rovira
Medicina Clinica
|
October 12, 2005
[Pachymeningitis as a first manifestation of an overlap vasculitic syndrome]
Carmen Tur, Jordi Río, Alex Rovira, et al.
Revista De Neurologia
|
July 24, 2015
[Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis]
Celia Oreja-Guevara, Jordi Río, Ana L Gobartt, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 103) with videos related to
Sort By:
Page
of 11
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 14, 2015
Any evident MRI T2 lesion activity should guide change of therapy in multiple sclerosis: no
Jordi Río
Medicina Clinica
|
March 4, 2015
[Current description of multiple sclerosis]
Jordi Río, Xavier Montalbán
Expert Opinion on Pharmacotherapy
|
December 2, 2005
Interferon-beta 1b in the treatment of multiple sclerosis
Jordi Río, Xavier Montalban
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 20, 2018
Clinical commentary on "Two cases of anaphylactic shock by methylprednisolone in neuromyelitis optica"
Breogán Rodríguez-Acevedo, Jordi Río
Current Opinion in Neurology
|
April 19, 2011
Multiple sclerosis: current treatment algorithms
Jordi Río, Manuel Comabella, Xavier Montalban
Journal of the Neurological Sciences
|
January 27, 2016
Short-term suboptimal response criteria for predicting long-term non-response to first-line disease modifying therapies in multiple sclerosis: A systematic review and meta-analysis
Jordi Río, Juan Luís Ruiz-Peña
Nature Reviews. Neurology
|
October 2, 2009
Predicting responders to therapies for multiple sclerosis
Jordi Río, Manuel Comabella, Xavier Montalban
Neuroimaging Clinics of North America
|
April 11, 2017
MR Imaging in Monitoring and Predicting Treatment Response in Multiple Sclerosis
Jordi Río, Cristina Auger, Àlex Rovira
Medicina Clinica
|
October 12, 2005
[Pachymeningitis as a first manifestation of an overlap vasculitic syndrome]
Carmen Tur, Jordi Río, Alex Rovira, et al.
Revista De Neurologia
|
July 24, 2015
[Compliance of the guidelines of the Spanish Neurology Society in the treatment of patients with multiple sclerosis]
Celia Oreja-Guevara, Jordi Río, Ana L Gobartt, et al.
Page
of 11